IQVIA Holdings Issues €950 Million Senior Notes Offering
Introducing TipRanks MCP for Agents
- Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
- Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.
IQVIA Holdings ( (IQV) ) has provided an announcement.
On June 11, 2026, IQVIA Inc., a subsidiary of IQVIA Holdings, completed a €950 million issuance of 4.625% senior notes due June 15, 2033, under an indenture with U.S. Bank Trust Company, National Association, acting as trustee and certain subsidiaries serving as guarantors. The unsecured notes, which pay interest semi-annually starting December 15, 2026, include provisions for early redemption with a make-whole premium through June 15, 2029 and a declining call premium thereafter.
IQVIA plans to use the net proceeds from the offering to refinance portions of its existing indebtedness and cover related fees and expenses, signaling an effort to optimize its capital structure and potentially lower financing costs. The transaction further extends the company’s debt maturity profile in euros, which may strengthen its financial flexibility and support ongoing operations for stakeholders across its global life sciences customer base.
The most recent analyst rating on (IQV) stock is a Buy
with a $210.00 price target.
To see the full list of analyst forecasts on IQVIA Holdings stock,
see the IQV Stock Forecast page.
Spark’s Take on IQV Stock
According to Spark, TipRanks’ AI Analyst, IQV is a Outperform.
The score is driven primarily by solid financial performance (notably strong cash flow) and a supportive earnings update (raised EPS guidance, strong bookings/backlog), partially offset by leverage-related balance-sheet risk, only moderate valuation support at ~22x earnings with no dividend yield provided, and a technical picture that is improving but still below the longer-term 200-day trend.
To see Spark’s full report on IQV stock,
click here.
More about IQVIA Holdings
IQVIA Holdings Inc., through its wholly owned subsidiary IQVIA Inc., operates in the life sciences industry, providing data, analytics, technology and clinical research services to pharmaceutical, biotech and healthcare clients. The company frequently taps global capital markets to support its financing strategy and manage its debt profile across multiple currencies and maturities.
Average Trading Volume: 1,618,719
Technical Sentiment Signal: Hold
Current Market Cap: $30.4B
See more insights into IQV stock on TipRanks’ Stock Analysis page.
